Unknown NA INTERVENTIONAL 2-arm NCT01723059

Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection

Conventional Therapy vs Sequential Therapy for the Treatment of Helicobacter Pylori Infection

Sponsor: Dallas VA Medical Center

Interventions Sequential Therapy Standard Triple Therapy

Updated 5 times since 2017 Last updated: Nov 5, 2012 Started: Feb 29, 2012 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Helicobacter Infection and is currently ongoing. Dallas VA Medical Center leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2017 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dallas VA Medical Center
Otsuka Pharmaceutical Development & Commercialization, Inc.

Data source: Dallas VA Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States